In Vitro Drug Release Testing of Special Dosage Forms Advances in Pharmaceutical Technology 1st Edition by Nikoletta Fotaki, Sandra Klein – Ebook PDF Instant Download/Delivery: 9781118341476 ,1118341473
Full download In Vitro Drug Release Testing of Special Dosage Forms Advances in Pharmaceutical Technology 1st Edition after payment
Product details:
ISBN 10: 1118341473
ISBN 13: 9781118341476
Author: Nikoletta Fotaki, Sandra Klein
In Vitro Drug Release Testing of Special Dosage Forms Advances in Pharmaceutical Technology 1st Edition Table of contents:
Part I: Oral Dosage Forms
1 Lipid‐Based Oral Formulations
1.1 Introduction
1.2 Levels of Release Testing for Lipid‐Based Dosage Forms
1.3 Case Examples
1.4 Conclusions and Future Directions
References
2 Chewable Oral Drug Products
2.1 Introduction
2.2 The Oral Cavity
2.3 Drug Substances Used in Chewable Dosage Forms
2.4 Technology
2.5 Pharmacopoeial Requirements
2.6 Summary and Conclusion
References
Part II: Non‐oral Dosage Forms
3 Injectables
3.1 Introduction
3.2 Significance of In Vitro Release Testing
3.3 Considerations in Method Development
3.4 In Vitro Release Methods
3.5 Dialysis Method
3.6 Accelerated In Vitro Release
3.7 In Vitro – In Vivo Correlations (IVIVCs)
References
4 Drug‐Eluting Stents
4.1 Drug‐Eluting Stents: Combination Products at the Interface of Medical Devices and Medicinal Products
4.2 DES Characteristics
4.3 In Vivo Stent Position and the Resulting Challenges for In Vitro Release Testing of Coronary Stents
4.4 Guidelines, Prerequisites, and General Recommendations on DES Testing
4.5 Currently Used Test Methods
4.6 Toward More Biorelevant Testing Conditions and New Challenges for DES Testing
4.7 Non‐Vascular Stents
4.8 Drug‐Coated Balloons: An Alternative to DESs for a Wide Range of Indications?
4.9 Concluding Remarks
References
5 In Vitro Dissolution for Inhalation Products
5.1 Introduction
5.2 The Environment of the Human Lungs
5.3 Regulatory Perspectives and Current Practices for Testing Inhaled Products
5.4 Simulated Lung Fluids
5.5 Pulmonary Biopharmaceutical Classification System
5.6 Conclusions
References
6 Topicals and Transdermals
6.1 Introduction
6.2 In Vitro Release Studies for Topical Dosage Forms
6.3 In Vitro Release Studies for Transdermal Systems
6.4 Conclusions
References
7 Vaginal and Intrauterine Delivery Systems
7.1 Vaginal and Uterine Anatomy and Physiology Relevant to Drug Delivery
7.2 Vaginal and Intrauterine Drug Delivery
7.3 Standard Dissolution Test Methods for Vaginal and Intrauterine Delivery Systems
7.4 Predictive Dissolution Test Methods for Vaginal and Intrauterine Delivery Systems
References
8 Rectal Dosage Forms
8.1 Rectal Anatomy and Physiology Relevant to Drug Delivery
8.2 Rectal Drug Delivery
8.3 Standard Dissolution Test Methods for Rectal Dosage Forms
8.4 Predictive Dissolution Test Methods for Rectal Dosage Forms
References
9 Ophthalmic Dosage Forms
9.1 Introduction
9.2 The Tear Film
9.3 Delivery Volume
9.4 Ophthalmic Formulations
9.5 In Vitro Testing for Ophthalmic Formulations
9.6 Concluding Remarks
References
10 Regulatory Considerations
10.1 Introduction
Part One: Review of Documents Related to In Vitro Release Testing
10.2 Compendial Chapters with Legal Implications
10.3 Compendial Chapters, Non‐binding
10.4 Guidances Related to In Vitro Release Testing
Part Two: Role of Method Development in Setting Clinically Relevant Specifications
10.5 Considerations in Early Method Development
10.6 Choice of Media
10.7 Discriminatory Power of the Method
10.8 In Vitro Release Testing for Special Dosage Forms
10.9 Resources
Bibliography
Acknowledgments
References
Index
People also search for In Vitro Drug Release Testing of Special Dosage Forms Advances in Pharmaceutical Technology 1st Edition:
in vitro drug testing protocol
in vitro drug release testing of special dosage forms pdf
in vitro drug testing
in vitro drug release test
in vitro release testing guidelines
Tags: Nikoletta Fotaki, Sandra Klein, Vitro Drug Release, Special Dosage, Pharmaceutical Technology